References

1. 1.
   GONG T，LUO Z，HUANG L，et al.Effect and mechanism of Yisui Fuyongtang （YSFYT） decoction on cognitive function and synaptic plasticity in rats with vascular cognitive impairment［J］.J Immunol Res，2022，2022：1709360.
2. 2.
   RUNDEK T，TOLEA M，ARIKO T，et al.Vascular Cognitive Impairment （VCI）［J］.Neurotherapeutics，2022，19 （1）：68-88.
3. 3.
   LI H，WANG L.Progress in pathophysiological mechanisms of vascular cognitive impairment［J］. Chin J Pathophysiol，2021，37（2）：363-368.
4. 4.
   YUAN Y，TIAN Y，JIANG H，et al. Mechanism of PGC-1α-mediated mitochondrial biogenesis in cerebral ischemia- reperfusion injury［J］.Front Mol Neurosci，2023，16：1224964.
5. 5.
   GONG M，JIA J.Rutaecarpine mitigates cognitive impairment by balancing mitochondrial function through activation of the AMPK/PGC1α pathway［J］.Mol Neurobiol，2023，60（11）：6598-6612.
6. 6.
   ABU SHELBAYEH O ，ARROUM T，MORRIS S，et al.PGC-1α is a master regulator of mitochondrial lifecycle and ROS stress response［J］.Antioxidants （Basel），2023，12 （5）：1075.
7. 7.
   SZALARDY L，MOLNAR M，TOROK R，et al.Lack of age-related clinical progression in PGC-1α-deficient mice - implications for mitochondrial encephalopathies［J］.Behav Brain Res，2016，313：272-281.
8. 8.
   DING H M，LI Y J，QIN H W，et al.Mechanistic study of Tongmai Kaiqiao pill in the treatment of vascular dementia in rats based on HIF-1α/BNIP3 signaling pathway regulating mitochondrial autophagy［J］.Chin J Exp Tradit Med Form，2024，30（21）：52-60.
9. 9.
   ZHAO N N， LI Y J，QIN H W，et al.Changes in ferroptosis in hippocampal neurons of vascular dementia model rats treated with Tongmai Kaiqiao pill［J］.Chin J Tissue Eng Res，2025，29（7）：1401-1407.
10. 10.
    LI X Q，AI J C，LIU Q，et al.Studies on the mechanism of Zhifuxin on vascular cognitive impairment［J］.J Chin Med Mater，2018，41（1）：175-179.
11. 11.
    CHEN Y F，QU M，ZHANG J，et al.Treatment of vascular dementia from blood collaterals and Qi collaterals based on collateral disease theory［J］.World Chin Med，2024，19（9）：1276-1278，1285.
12. 12.
    WANG F M，LIU B，GAI P P， et al. A clinical study on Shouwu Yizhi formula combined with cognitive rehabilitation train-ing in the treatment of vascular cognitive impairment. ［J］. Clin J Chin Med，2023，15（30）：68-72.
13. 13.
    ZHANG J，TAO X J，MA X W，et al.The research progress on treating vascular dementia from the perspective of Zang-Fu theory［J］.Hubei J Tradit Chin Med，2024，46（1）：59-63.
14. 14.
    LU W W，GUO Y K.Systematic evaluation and Meta-analysis of the efficacy and safety of Buyang Huanwu decoction in the treatment of vascular cognitive impairment［J］.World Chin Med，2022，17（8）：1095-1100.
15. 15.
    ZHANG M，BAI Y J，SHEN X，et al.Ma Yunzhi's experience in the treatment of vascular dementia by tonifying the kidney and detoxifying［J］.Jilin J Chin Med，2022，42（8）：895-899.
16. 16.
    LIU L J，CAI H B，WANG J J，et al.Correlation between cognitive dysfunction and TCM syndromes（phlegm，stagnation and deficiency）in vascular cognitive impairment［J］.Chin Archives Trad Chin Med，2019， 37（11）：2686-2689.
17. 17.
    ZHU G W，ZHU R L，LI X M，The impact of Yangxue Yizhi Tang combined with acupuncture at the Four Shencong points on mild cognitive impairment after cerebral infarction［J］.TCM Res，2024，37（9）：52-55.
18. 18.
    LI Y Y，WANG X Q，LI C J，et al.Effect of Buyang Huanwu decoction combined with operation therapy on shoulder—hand syndrome after stroke and its effect on upper limb motor function［J］.Chin Archives Trad Chin Mede，2021，39（6）：192-195
19. 19.
    QU P，LUO L M，XU L，et al.Effects of Chaihu Shugan powder modified with jiangxiangru on intestinal inflammation and gut microbiota in obese and depressed rats［J］.Pharmacol Clin Chin Mater Med，2023，39（11）：9-17.
20. 20.
    HU Y F，WANG X，LIU Q，et al.Research progress of chinese medicine Fushen［J］.J Liaoning Univ Tradit Chin Med，2023，25（1）：115-121.
21. 21.
    LI D D，CHEN J.Research progress of Tongqiao Huoxue decoction in treatment of vascular cognitive impairment and dementia［J］.Chin Archives Tradit Chin Med，2024，42（10）：103-108.
22. 22.
    DUNCOMBE J，KITAMURA A，HASE Y，et al.Chronic cerebral hypoperfusion：A key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia［J］.Clin Sci （Lond），2017，131 （19）：2451-2468.
23. 23.
    OGNJANOVSKI N，SCHAEFFER S，WU J，et al. Parvalbumin-expressing interneurons coordinate hippocampal network dynamics required for memory consolidation［J］.Nat Commun，2017，8：15039.
24. 24.
    LEVIT A，HACHINSKI V，WHITEHEAD S N.Neurovascular unit dysregulation， white matter disease， and executive dysfunction： The shared triad of vascular cognitive impairment and Alzheimer disease［J］.Geroscience，2020，42 （2）：445-465.
25. 25.
    BATTLE C E，ABDUL-RAHIM A H，SHENKIN S D，et al.Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments： A network Meta-analysis［J］.Cochrane Database Syst Rev，2021，2 （2）：CD013306.
26. 26.
    SUN C，LIU M，LIU J，et al.Shenma Yizhi decoction improves the mitochondrial structure in the brain and ameliorates cognitive impairment in VCI rats via the AMPK/UCP2 signaling pathway［J］.Neuropsychiatr Dis Treat，2021，17：1937-1951.
27. 27.
    KIM E，PARK M，JEONG J，et al.Cholinesterase inhibitor donepezil increases mitochondrial biogenesis through AMP-activated protein kinase in the hippocampus［J］.Neuropsychobiology，2016，73 （2）：81-91.
28. 28.
    JORNAYVAZ F R，SHULMAN G I.Regulation of mitochondrial biogenesis［J］.Essays Biochem，2010，47：69-84.
29. 29.
    PALIKARAS K，TAVERNARAKIS N.Mitochondrial homeostasis：The interplay between mitophagy and mitochondrial biogenesis［J］.Exp Gerontol，2014，56：182-188.
30. 30.
    YAN Y，ZHOU X E，XU H E，et al.Structure and physiological regulation of AMPK［J］.Int J Mol Sci，2018，19 （11）：3534.
31. 31.
    JIANG S，LI T，JI T，et al.AMPK：Potential therapeutic target for ischemic stroke［J］.Theranostics，2018，8 （16）：4535-4551.
32. 32.
    LI P A，HOU X，HAO S.Mitochondrial biogenesis in neurodegeneration［J］.J Neurosci Res，2017，95 （10）：2025-2029.
33. 33.
    ZHANG S，WU X，WANG J，et al.Adiponectin/AdiopR₁ signaling prevents mitochondrial dysfunction and oxidative injury after traumatic brain injury in a SIRT3 dependent manner［J］.Redox Biol，2022，54：102390
34. 34.
    LI L，XIAO L，HOU Y，et al.Sestrin2 silencing exacerbates cerebral ischemia/reperfusion injury by decreasing mitochondrial biogenesis through the AMPK/PGC-1α pathway in rats［J］.Sci Rep，2016，6：30272.
35. 35.
    HAN B，JIANG W，LIU H，et al.Upregulation of neuronal PGC-1α ameliorates cognitive impairment induced by chronic cerebral hypoperfusion［J］.Theranostics，2020，10 （6）：2832-2848.
36. 36.
    CHEN S D，LIN T K，LIN J W，et al.Activation of calcium/calmodulin-dependent protein kinase Ⅳ and peroxisome proliferator-activated receptor γ coactivator-1α signaling pathway protects against neuronal injury and promotes mitochondrial biogenesis in the hippocampal CA1 subfield after transient global ischemia［J］.J Neurosci Res，2010，88 （14）：3144-3154.